During the past decade, Advagene Biopharma conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Advagene Biopharma" are "Covid19" (1 trials) and "Influenza Infection" (1 trials). Many other conditions were trialed in "Advagene Biopharma" in a lesser frequency.

Most popular intervention types in "Advagene Biopharma" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "AD07010" (1 trials), "AD17002" (1 trials), "Inactivated trivalent influenza vaccine" (1 trials) and "Placebo (Formulation buffer)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Advagene Biopharma" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Advagene Biopharma". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Advagene Biopharma, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Advagene Biopharma, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".